TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer

Virginie Maire(Institut Curie), Thierry Dubois(Translational Research Institute)

PLoS ONE

May 20, 2013

10.1371/journal.pone.0063712

Cited by 168

Related Papers

Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells

|Breast Cancer Research|2008|211

Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells

|PLoS ONE|2015|89

PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer

|Cancers|2022|35

LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers

|Oncotarget|2018|33

LRP8 is overexpressed in estrogen‐negative breast cancers and a potential target for these tumors

|Cancer Medicine|2018|22